MIRA Pharmaceuticals (MIRA) Stock Chart & Stock Price History → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free MIRA Stock Alerts $0.82 +0.02 (+2.51%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends MIRA Pharmaceuticals Stock Price Performance5 Day Performance-7.55%1 Month Performance-0.13%3 Month Performance-21.32%6 Month Performance-78.47%Year-To-Date Performance-22.08% Receive MIRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wealthpin ProThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. MIRA Stock Chart for Sunday, June, 2, 2024 MIRA Chart by TradingView MIRA Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.80$0.82+2.28%$0.89$0.7569,691 shs$12.09 million05/30/2024$0.88$0.80-8.98%$0.90$0.70121,373 shs$11.82 million05/29/2024$0.85$0.88+3.39%$0.95$0.80494,110 shs$12.99 million05/28/2024$0.89$0.85-3.94%$0.88$0.8282,159 shs$12.56 million05/27/2024$0.89$0.89$0.90$0.8670,300 shs$13.08 million05/24/2024$0.88$0.89+0.57%$0.90$0.8670,378 shs$13.08 million Get the Latest News and Ratings for MIRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.92$0.88-3.89%$0.96$0.85123,527 shs$13.01 million05/22/2024$1.02$0.92-10.24%$1.18$0.841.11 million shs$13.53 million05/21/2024$0.85$1.02+20.00%$1.04$0.77562,604 shs$15.08 million05/20/2024$0.66$0.85+29.77%$0.98$0.712.23 million shs$12.56 million05/17/2024$0.68$0.66-3.61%$0.71$0.6374,728 shs$9.68 million05/16/2024$0.71$0.68-4.34%$0.75$0.6488,546 shs$10.04 million05/15/2024$0.74$0.71-3.79%$0.73$0.7042,972 shs$10.50 million05/14/2024$0.72$0.74+2.96%$0.77$0.7158,266 shs$10.91 million05/13/2024$0.72$0.72-0.40%$0.77$0.7034,710 shs$10.60 million05/10/2024$0.75$0.72-4.00%$0.79$0.7175,914 shs$10.64 million05/09/2024$0.76$0.75-1.30%$0.76$0.739,872 shs$11.09 million05/08/2024$0.76$0.76-0.01%$0.81$0.739,096 shs$11.23 million05/07/2024$0.75$0.76+1.33%$0.79$0.7316,077 shs$11.23 million05/06/2024$0.73$0.75+2.32%$0.80$0.7369,926 shs$11.09 million05/03/2024$0.80$0.79-1.95%$0.86$0.72324,318 shs$11.62 million05/02/2024$0.82$0.80-2.16%$0.84$0.8024,062 shs$11.85 million05/01/2024$0.85$0.82-3.61%$0.85$0.8021,365 shs$12.11 million04/30/2024$0.85$0.85$0.85$0.8214,866 shs$12.56 million04/29/2024$0.86$0.85-1.14%$0.89$0.8516,527 shs$12.56 million04/26/2024$0.90$0.86-4.47%$0.92$0.8512,549 shs$12.71 million04/25/2024$0.87$0.90+3.45%$0.90$0.8720,404 shs$13.30 million04/24/2024$0.88$0.87-0.92%$0.90$0.8513,077 shs$12.86 million04/23/2024$0.86$0.88+2.10%$0.90$0.8732,710 shs$12.98 million04/22/2024$0.83$0.86+3.42%$0.87$0.8521,644 shs$12.71 million04/19/2024$0.87$0.83-3.86%$0.86$0.7953,258 shs$12.29 million04/18/2024$0.81$0.87+6.82%$0.89$0.8017,217 shs$12.79 million04/17/2024$0.79$0.81+2.51%$0.91$0.7860,735 shs$11.97 million04/16/2024$0.83$0.79-4.82%$0.85$0.7663,940 shs$11.68 million04/15/2024$0.90$0.83-7.83%$0.90$0.8051,553 shs$12.27 million04/12/2024$1.00$0.90-9.83%$0.98$0.8875,968 shs$13.31 million04/11/2024$1.00$1.00-0.03%$1.01$0.9619,460 shs$14.76 million04/10/2024$1.02$1.00-2.06%$1.02$0.9648,394 shs$14.77 million04/09/2024$1.03$1.02-0.97%$1.04$1.0018,207 shs$15.08 million04/08/2024$1.02$1.03+0.98%$1.06$1.0128,526 shs$15.22 millionThe only financial event in 2024 that matters (Ad)Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here04/05/2024$1.02$1.02$1.04$1.00102,637 shs$15.08 million04/04/2024$1.07$1.02-4.67%$1.09$1.0266,926 shs$15.08 million04/03/2024$1.07$1.07$1.07$1.0249,019 shs$15.82 million04/02/2024$1.08$1.07-0.93%$1.11$1.02157,991 shs$15.82 million04/01/2024$1.10$1.08-1.82%$1.12$1.0545,811 shs$15.96 million03/29/2024$1.10$1.10$1.18$1.09140,708 shs$16.26 million03/28/2024$1.09$1.10+0.92%$1.18$1.09140,628 shs$16.26 million03/27/2024$1.15$1.09-5.22%$1.18$1.07139,802 shs$16.11 million03/26/2024$1.16$1.15-0.86%$1.17$1.1137,681 shs$17.00 million03/25/2024$1.23$1.16-5.69%$1.27$1.1563,892 shs$17.15 million03/22/2024$1.26$1.23-2.38%$1.27$1.2077,373 shs$18.18 million03/21/2024$1.24$1.26+1.61%$1.44$1.20236,641 shs$18.62 million03/20/2024$1.19$1.24+4.20%$1.28$1.15138,912 shs$18.33 million03/19/2024$1.18$1.19+0.85%$1.21$1.13107,148 shs$17.59 million03/18/2024$1.18$1.18$1.22$1.12156,532 shs$17.44 million03/15/2024$1.23$1.18-4.07%$1.23$1.05236,300 shs$17.44 million03/14/2024$1.10$1.23+11.82%$1.30$1.04543,307 shs$18.18 million03/13/2024$1.55$1.10-29.03%$1.59$1.04714,814 shs$16.26 million03/12/2024$1.50$1.55+3.33%$1.68$1.421.07 million shs$22.91 million03/11/2024$1.57$1.50-4.46%$1.84$1.403.68 million shs$22.17 million03/08/2024$0.92$1.57+71.40%$1.57$1.1825.94 million shs$23.21 million03/07/2024$0.96$0.92-4.08%$0.96$0.92749,089 shs$13.54 million03/06/2024$0.93$0.96+2.69%$0.99$0.9144,167 shs$14.12 million03/05/2024$0.99$0.93-6.06%$1.01$0.9187,018 shs$13.75 million03/04/2024$1.04$0.99-4.80%$1.02$0.9730,017 shs$14.63 million03/01/2024$1.01$1.04+3.47%$1.04$0.9837,692 shs$15.37 million02/29/2024$1.00$1.01+0.50%$1.05$0.9670,314 shs$14.85 million Related Companies: FSD Pharma Stock Chart Imunon Stock Chart RedHill Biopharma Stock Chart Kiora Pharmaceuticals Stock Chart Elevai Labs Stock Chart Pieris Pharmaceuticals Stock Chart Vincerx Pharma Stock Chart Akari Therapeutics Stock Chart ABVC BioPharma Stock Chart Moleculin Biotech Stock Chart Receive MIRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MIRA) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.